Podrobno

Karakterizacija toplotno obdelanega jekla NICRODUR 400 : magistrsko delo
ID Balaško, Tilen (Avtor), ID Nagode, Aleš (Mentor) Več o mentorju... Povezava se odpre v novem oknu, ID Klančnik, Grega (Komentor)

.pdfPDF - Predstavitvena datoteka, prenos (10,39 MB)
MD5: F3CDDE7D6847A4311B4AF0C25723A29F
PID: 20.500.12556/rul/1cc58db9-9e44-499a-8577-af296ec5cb30

Jezik:Slovenski jezik
Ključne besede:jeklo NICRODUR 400, karakterizacija, avstenitizacija, toplotna obdelava, mikrostruktura
Vrsta gradiva:Diplomsko delo/naloga
Organizacija:NTF - Naravoslovnotehniška fakulteta
Kraj izida:Ljubljana
Založnik:[T. Balaško]
Leto izida:2016
Št. strani:XI, 75 f. pril.
PID:20.500.12556/RUL-87675 Povezava se odpre v novem oknu
UDK:669.1
COBISS.SI-ID:1628255 Povezava se odpre v novem oknu
Datum objave v RUL:08.12.2016
Število ogledov:24627
Število prenosov:903
Metapodatki:XML DC-XML DC-RDF
:
BALAŠKO, Tilen, 2016, Karakterizacija toplotno obdelanega jekla NICRODUR 400 : magistrsko delo [na spletu]. Magistrsko delo. Ljubljana : T. Balaško. [Dostopano 6 april 2025]. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=87675
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Ključne besede:NICRODUR 400 steel, characterization, austenitization, heat treatment, microstructure

Podobna dela

Podobna dela v RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Podobna dela v drugih slovenskih zbirkah:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Nazaj